Table 1 Patient characteristics (n = 45)
From: Galectin-1 is a poor prognostic factor in patients with glioblastoma multiforme after radiotherapy
Parameter | Gal-1 expression (weak) | Gal-1 expression (strong) | p value |
|---|---|---|---|
Age (years) | Â | Â | 0.464 |
  <  50 | 5 (45.5%) | 10 (29.4%) |  |
 ≥ 50 | 6 (54.5%) | 24 (70.6%) |  |
Gender | Â | Â | 0.732 |
 Female | 5 (45.5%) | 13 (38.2%) |  |
 Male | 6 (54.5%) | 21 (61.8%) |  |
ECOG | Â | Â | 1.000 |
 0–2 | 8 (72.7%) | 26 (76.5%) |  |
 3–4 | 3 (27.3%) | 8 (23.5%) |  |
Tumor size | Â | Â | 0.897 |
  <  5 cm | 3 (27.3%) | 7 (20.6%) |  |
 ≥ 5 cm | 2 (18.2%) | 7 (20.6%) |  |
 Unknown | 6 (54.5%) | 20 (58.8%) |  |
OP method | Â | Â | 0.525 |
 gross total removal | 8 (72.7%) | 17 (50.0%) |  |
 subtotal removal + biopsy | 3 (27.3%) | 14 (41.2%) |  |
 unknown | 0 (0%) | 3 (8.8%) |  |
RT field | Â | Â | 0.736 |
 Small | 7 (63.6%) | 19 (55.9%) |  |
 Whole brain | 4 (36.4%) | 15 (44.1%) |  |
EQD2 (Gy) | Â | Â | 0.987 |
 Mean | 66.36 | 66.38 |  |
 SEM | 0.67 | 0.46 |  |